Birdwatch Note
2024-12-12 17:16:33 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
GLP-1 agonists are specific to people with diabetes. There are no medications to make you healthier, but medications can improve your disease status. All medications have side effects that should be discussed with your doctor. https://my.clevelandclinic.org/health/treatments/13901-glp-1-agonists
Written by 4EB94F6C66555C8DFBB2A7ED4EB8E77A60912F17AC2D1C12BE9CAA97613EA200
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1866897670352036050
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1867257245462905276
- noteId - 1867257245462905276
- participantId -
- noteAuthorParticipantId - 4EB94F6C66555C8DFBB2A7ED4EB8E77A60912F17AC2D1C12BE9CAA97613EA200
- createdAtMillis - 1734023793938
- tweetId - 1866897670352036050
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- GLP-1 agonists are specific to people with diabetes. There are no medications to make you healthier, but medications can improve your disease status. All medications have side effects that should be discussed with your doctor. https://my.clevelandclinic.org/health/treatments/13901-glp-1-agonists
Note Ratings
| rated at | rated by | |
| 2024-12-13 07:45:37 -0600 | Rating Details | |
| 2024-12-12 13:54:53 -0600 | Rating Details |